Celularity (CELU)
(Delayed Data from NSDQ)
$3.25 USD
+0.01 (0.31%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $3.31 +0.06 (1.85%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Celularity, Inc. [CELU]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Celularity, Inc.
Industry: Unclassified
Company: Celularity, Inc.
Industry: Unclassified
Distribution Partnership Leads to a Purchase Order; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Celularity, Inc.
Industry: Unclassified
Strategic Shift to Focus on Near-term Revenue; Pipeline Revisited; Lower to $2.50 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Celularity, Inc.
Industry: Unclassified
Distributor Partnerships Expected to Bring Immediate Upside; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Celularity, Inc.
Industry: Unclassified
CYNK-001 Readouts Remain On Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Celularity, Inc.
Industry: Unclassified
CYNK-001 Data Readout Anticipated in 2H22; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Celularity, Inc.
Industry: Unclassified
Placental-Derived Immunotherapies; Initiate With Buy and a $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Celularity, Inc.
Industry: Unclassified
"Natural Born Killers" An Update in NK Cell Therapy
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
|